Skip to content
10-Q

Quarterly Report

LIMINATUS PHARMA, INC. LIMN LIMNW

0001104659-25-096872

← back to feed
Filed
Oct 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Oct 3, 2025 27.06M sh
Shares Diluted Q2 2025 · Jun 30, 2025 23.3M sh
Shares Diluted Q2 2025 · Jun 30, 2025 20.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 17.5M sh
Shares Diluted Q2 2025 · Jun 30, 2024 17.5M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$8.98M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.1M
Short Term Debt Q2 2025 · Jun 30, 2025 $1.44M
Short Term Debt Q2 2025 · Dec 31, 2024 $19.97M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$8.81M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$19.67M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$19.34M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$18.51M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$17.55M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$15.79M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.52M
Current Liabilities Q2 2025 · Dec 31, 2024 $24.75M
Total Liabilities Q2 2025 · Jun 30, 2025 $10.72M
Total Liabilities Q2 2025 · Dec 31, 2024 $24.75M
Current Assets Q2 2025 · Jun 30, 2025 $1.78M
Current Assets Q2 2025 · Dec 31, 2024 $5.28M
Total Assets Q2 2025 · Jun 30, 2025 $1.91M
Total Assets Q2 2025 · Dec 31, 2024 $5.41M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.16
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.05
Eps Basic Q2 2025 · Jun 30, 2024 −$0.16
Sga Expense Q2 2025 · Jun 30, 2025 $1.12M
Sga Expense Q2 2025 · Jun 30, 2025 $1.38M
Sga Expense Q2 2025 · Jun 30, 2024 $195.08K
Sga Expense Q2 2025 · Jun 30, 2024 $291.46K
Net Income Q2 2025 · Jun 30, 2025 $113.29K
Net Income Q2 2025 · Jun 30, 2025 −$214.24K
Net Income Q2 2025 · Mar 31, 2025 −$327.53K
Net Income Q2 2025 · Jun 30, 2024 −$961.21K
Net Income Q2 2025 · Jun 30, 2024 −$2.72M
Net Income Q2 2025 · Mar 31, 2024 −$1.75M
Operating Income Q2 2025 · Jun 30, 2025 −$1.12M
Operating Income Q2 2025 · Jun 30, 2025 −$1.38M
Operating Income Q2 2025 · Jun 30, 2024 −$909.22K
Operating Income Q2 2025 · Jun 30, 2024 −$2.62M
Rd Expense Q2 2025 · Jun 30, 2024 $714.13K
Rd Expense Q2 2025 · Jun 30, 2024 $2.33M